globenewswire news
2026-09-25T22:54:00Z
Strategic collaboration expands no-cost access to trusted in-person and virtual mental health services, helping employers simplify care while improving affordability and access for employees and their families.
2026-09-25T21:49:16Z
The three-day congress features keynote speaker Robert Herjavec and a live Venture Forum where healthcare founders pitch to investors and strategic partners.
2026-09-25T21:30:00Z
User Survey Demonstrates High Satisfaction of the LIBERTY System
2026-09-25T21:19:00Z
With over 100 Canadian-made supplements, Herba earns its second consecutive appearance and ranks No. 9 in the Health Care & Wellness category.
2026-09-25T21:00:00Z
SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced...
2026-09-25T21:00:00Z
EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life...
2026-09-25T20:30:00Z
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic diseases by targeting the...
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
2026-09-25T20:30:00Z
VANCOUVER, British Columbia, Sept. 25, 2026 (GLOBE NEWSWIRE) -- NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and...
2026-09-25T20:15:00Z
WALTHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies...
2026-09-25T17:05:00Z
Data presented at the AACR Conference on Pancreatic Cancer indicate Annamycin’s antitumor activity is partially mediated by CD8+ T cells, supporting a potential immune-mediated mechanism alongside its direct cytotoxic activity
2026-09-25T17:00:00Z
NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel...
2026-09-25T16:00:00Z
Orion Corporation: Acquisition of own shares during week 39, 2026
2026-09-25T15:50:00Z
MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced...
2026-09-25T15:45:00Z
Ad hoc announcement pursuant to Art. 53 LR
2026-09-25T14:30:00Z
Leiden, the Netherlands, September 25, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has...
2026-09-25T13:37:47Z
MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top...
2026-09-25T13:33:56Z
SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report,...
2026-09-25T13:05:20Z
Company to feature surgeon-led educational programming and technologies supporting liver surgery
2026-09-25T13:04:51Z
DENVER, Sept. 25, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- A completed library of living genetic building blocks positions Kraig Biocraft Laboratories (OTCQB: KBLB) to explore more than 200 potential configurations...
2026-09-25T13:00:00Z
IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a...
2026-09-25T13:00:00Z
NEW YORK and LONDON and LEAMINGTON, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged...
2026-09-25T13:00:00Z
SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of...
2026-09-25T13:00:00Z
One of two prime awardees on the $775.72 million multiple-award IDIQ, Knowtex is expanding AI that gives clinicians more time with Veterans. It's already live at 79 VA medical centers...
2026-09-25T12:30:00Z
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026
2026-09-25T12:10:00Z
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a...
2026-09-25T12:03:01Z
Definition requires five years off myeloma treatment with sustained MRD negativity, assessed with technology sensitive enough to identify one myeloma cell among one million cells
2026-09-25T12:00:00Z
Munich, Germany and Alpharetta, GA, United States, September 25, 2026 - neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, and the company...
2026-09-25T11:45:00Z
– Partnership will introduce NeuroSigma’s second-generation Monarch eTNS® System to Firefly’s nationwide network of Evoke™ clinicians –
2026-09-25T11:30:00Z
Management to provide updates on recent developments including diagnostic billing, market access & growth plans
2026-09-25T11:16:19Z
BEERSE, BELGIUM, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson, a worldwide leader in multiple myeloma, announced today new long-term follow-up data from the initial subgroup of cohort A...
2026-09-25T11:02:00Z
MALVERN, Pa., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that OCU400...
2026-09-25T11:00:00Z
Five-year overall survival rate was 69.2%, adding to growing long-term evidence supporting the curative potential of CARVYKTI in earlier-line RRMM
2026-09-25T11:00:00Z
Immunomodulatory Effects of Cemsidomide with Dexamethasone from Phase 1 Trial Demonstrated Robust T-cell Activation, a Key Component of Cemsidomide’s Dual Mechanism of Action
2026-09-25T11:00:00Z
$15.0 Million Award to Support Advancement of RECLAIM-LN, a Phase 2 Potentially Registrational Trial of FT819 Off-the-Shelf CAR T-Cell Therapy in Lupus Nephritis
2026-09-25T11:00:00Z
Jonathan Rigby and Will Rust, Ph.D., to Discuss Proposed Merger to Form BetaNova Biotherapeutics and Advance a Differentiated Type 1 Diabetes Cell-Replacement Platform
2026-09-25T11:00:00Z
Aiming to improve information sharing among medical staff and strengthen support systems for patients visiting from abroad
2026-09-25T07:00:00Z
Approval is based on NEXUS data and follows positive CHMP opinion in July; first European launch is expected by end of 2026
2026-09-25T06:00:00Z
LONDON and PHILADELPHIA, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, the "Company", "Avacta"), a life sciences company developing innovative, targeted oncology drugs, today announces the presentation of...
2026-09-25T05:30:00Z
DIJON, FRANCE, September 25, 2026 – 07h30 (CEST) – CROSSJECT (ISIN: FR0011716265; Euronext Growth: ALCJ), a Specialty Pharma company developing innovative solutions for emergency situations based on its proprietary ZENEO®...
2026-09-25T05:30:00Z
Cash and cash equivalents of €12.3 million as of June 30, 2026, a 2.4-fold increase compared to December 31, 2025 (€5.1 million), following the €15 million capital increase completed in May.
2026-09-25T05:00:00Z
Louvain-la-Neuve, Belgium, 25 September 2026, 7 a.m. CEST – IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, today announces it will coordinate the LIFEDESTINY, a...
2026-09-25T05:00:00Z
Ad Hoc Announcement Pursuant to Art. 53 LR
2026-09-24T23:33:11Z
SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced today the pricing of its upsized initial public...
2026-09-24T22:51:19Z
Blood biomarkers associated with amyloid clearance differ from those associated with cognitive decline in patients receiving lecanemab
2026-09-24T21:55:25Z
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli...
2026-09-24T20:30:00Z
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli...
2026-09-24T20:15:00Z
PARIS and CAMBRIDGE, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment...
2026-09-24T20:15:00Z
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
2026-09-24T20:06:32Z
The Bucks County-Based Mental Health Practice Introduces a Licensed Clinical Psychologist to Its Team
2026-09-24T20:05:00Z
TARRYTOWN, N.Y., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2026 financial and operating results on Friday, October...